Here's an overview of the latest developments: 🧪 Emerging Medications 1. MM120 (LSD-based therapy) Developed by MindMed, MM120 is undergoing Phase 3 clinical trials for Generalized Anxiety Disorder (GAD). Early results indicate rapid and sustained symptom relief, positioning it as a potential breakthrough in anxiety treatment. 2. Exxua & Zuranolone These novel antidepressants are designed to act swiftly with fewer side effects compared to traditional SSRIs. Zuranolone, in particular, h...

This is HEALTH OVA website created by Yaseen Official. HEALTH OVA falls in LOCAL BUSINESS line of business. You can visit us offline at our office located at : khwazakhela swat, Peshawar, Khyber Pakhtunkhwa, Pakistan - 19110 You can contact us by phone - 3442247910 or email us on yaseenofficial64@gmail.com or use the Contact Form. This is...